Information Provided By:
Fly News Breaks for October 11, 2017
Oct 11, 2017 | 08:55 EDT
Credit Suisse analyst Erin Wilson Wright reinstated coverage of INC Research with an Outperform rating and $68 price target as she views it as well positioned in healthy CRO and CCO industries that are growing 6%-8% annually, fueled by sustained strength in outsourcing demand across R&D and commercial functions in an increasingly onerous regulatory and reimbursement environment for biopharma customers.
News For INCR From the Last 2 Days
There are no results for your query INCR
Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.

TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.